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Radiographic contrast media–induced tubular injury: Evalua- ways have been widely discussed. First, radiocontrast
tion of oxidant stress and plasma membrane integrity. medium (RCM) injection induces renal vasoconstriction
Background. Experimental and clinical investigations sug- [2, 3], a process that is thought to arise from an imbalancegest that oxidant stress is a critical determinant of radiocontrast
between endothelium-derived vasoconstrictive and vaso-nephropathy (RCN), and that N acetyl cysteine (NAC) can
prevent this damage. This study addresses these issues directly dilatory factors (e.g., endothelin, nitric oxide, and adeno-
at the tubular cell level. Potential alternative mechanisms for sine) [4–10]. If severe vasoconstriction is induced, isch-
RCN have also been sought. emic tubular injury, culminating in cell detachment,Methods. Isolated mouse proximal tubule segments (PTS),
apoptosis, or necrosis can each result [11, 12]. Proximalor cultured proximal tubule (HK-2) cells, were subjected to
tubules and medullary thick ascending limbs [12] areradiocontrast media (RCM) (Ioversol, Optiray 320) exposure,
followed by assessments of cellular viability [% lactate dehy- particularly vulnerable to these events. Second, follow-
drogenase (LDH) release, tetrazolium dye (MTT), uptake] and ing tissue ischemia, “reperfusion injury” may occur. This
lipid peroxidation. These experiments were conducted in the
may arise from a number of factors, such as oxidativeabsence or presence of a variety of antioxidants [NAC, glutathi-
stress [11] or “re-alkalinization injury,” induced by aone (GSH), superoxide dismutase, catalase] or pro-oxidant (GSH
depletion, heme oxygenase inhibition) strategies. RCM effects rapid correction of ischemia-induced reductions in tissue
on mitochondrial and plasma membrane integrity were also pH [13]. Third, RCM may precipitate in distal tubule
assessed.
lumina along with Tamm Horsfall glycoprotein, formingResults. RCM exposure did not induce PTS lipid peroxida-
casts [14–16]. To the extent that sloughed tubular cellstion. Neither antioxidant nor pro-oxidant interventions miti-
gated or exacerbated RCM-induced tubular cell injury, respec- are incorporated into these casts, a worsening of intra-
tively. RCM impaired mitochondrial integrity, as assessed by tubular obstruction may result. Fourth, RCM can di-
ouabain-resistant ATP reductions, and by cytochrome c release rectly damage tubular cells. This can potentially arise(before cell death). RCM also induced plasma membrane dam-
from either RCM-induced elevations in tissue osmolalityage, as indicated by loss of key resident proteins (NaK-ATPase,
caveolin) and by increased susceptibility to phospholipase A2 [17, 18], or from direct contrast-induced cytotoxicity. In
(PLA2) attack (increase of 2 times in free fatty acid and this regard, Humes et al [19] reported that RCM (but
NaK-ATPase release). Hyperosmolality could not account for not the associated hyperosmolality) causes sublethal in-RCM’s toxic effects.
jury in isolated rabbit proximal tubules, as reflected byConclusion. RCM toxicity can be dissociated from tubular
decreases in mitochondrial respiration, cellular K leak,cell oxidant stress. Alternative mechanisms may include mito-
chondrial injury/cytochrome c release and plasma membrane and a Ca2 overload state. The pathologic mechanisms
damage. The latter results in critical protein loss, as well as a by which RCM induced these changes were not defined.
marked increase in plasma membrane susceptibility to exoge-
However, investigations from a number of laboratoriesnous/endogenous PLA2 attack.
suggest that oxidative tubular stress is involved. This
conclusion is supported by findings that RCM injection
can induce or exacerbate lipid peroxidation in eitherRadiocontrast nephropathy (RCN) is a leading cause
normal or dehydrated rats [20, 21]. The fact that adminis-of acute renal failure (ARF) [1]. However, its pathogene-
tration of N-acetyl cysteine (NAC) to humans may miti-sis remains poorly defined. Four dominant injury path-
gate RCN further supports this view [22, 23].
Progress towards preventing RCN will require addi-Key words: acute renal failure, caveolin, phospholipase A2, cytochrome c,
NaK-ATPase, oxidant stress. tional understanding of involved pathogenic mechanisms.
Hence, the present study was undertaken with the fol-Received for publication November 27, 2002
lowing goals in mind. First, define whether RCM does,and in revised form January 14, 2003
Accepted for publication February 24, 2003 in fact, induce critical oxidative stress in renal tubular
cells. If so, can antioxidants, in general, and NAC, in 2003 by the International Society of Nephrology
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reoxygenation (95% O2/5% CO2); and (6) 15 minutesparticular, mitigate this damage? Second, since NAC is
of NAC treatment followed by hypoxia/reoxygenation.currently widely used as prophylaxis for RCN, ascertain
Thus, the total incubations were 45 minutes, with a 15-the spectrum and molecular determinants of its pur-
minute preincubation period  NAC. At the end of theported cytoprotective effects. Third, given that RCM
incubations, cell injury was assessed by % lactate dehydro-may induce mitochondrial injury [19] as well as tubular
genase (LDH) release [24].cell apoptosis [12, 17, 18], might these two events be
Glutathione (GSH) effects on oxidative and hypoxiclinked (e.g., via mitochondrial cytochrome c release, a
proximal tubular injury. The following experiment as-potential inducer of apoptosis)? Fourth, since radiocon-
certained whether NAC confers a greater degree of pro-trast agents are thought to be plasma membrane im-
tection than a comparable amount of GSH. Noteworthypermeant, might they alter plasma membrane integrity,
in this regard is that GSH, unlike NAC, is a sourceinducing either direct membrane damage and/or predis-
of glycine, a potent cytoprotectant against hypoxic cellposing the membrane to superimposed attack (e.g., by
damage [27]. Hence, it is conceivable that it might bePLA2)? Clinical RCN results from a complex interplay preferable to NAC as a cytoprotectant. To address thisof vascular, intraluminal, and tubular cell events. The
issue, the experiment described above was repeated (N
present investigations were confined to direct tubular 4 PTS preparations), except that 2 mmol/L of glutathione
cell experiments in order to focus on pathogenic events (GSH) was substituted for 2 mmol/L NAC.
at this level. N acetyl lysine (NAL) and N acetyl methionine (NAM)
effects on PTS injury. It is widely assumed that NAC’s
protective effect is imparted by its free sulfhydryl (SH)METHODS
group. However, it remains possible that its acetyl moi-
Proximal tubule segment experiments ety, or possibly its sulfur content, per se, could be respon-
Isolated proximal tubule segment (PTS) preparation. sible. To exclude these possibilities, the impacts of NAL
Proximal tubules were isolated from normal CD-1 male and NAM on Fe-mediated oxidative stress were assessed
mice (25 to 35 g; Charles River, Wilmington, MA, USA) (NAL contains an acetyl, but not an SH group; NAM
as previously described [24]. They were suspended in contains sulfur, but not an SH group). Three sets of
an experimentation buffer (NaCl 100 mmol/L; KCl 2.1 PTS were prepared and each divided into 6 1 mL aliquots
mmol/L; NaHCO3 25 mmol/L; KH2PO4 2.4 mmol/L; containing control incubation; incubation with 2 mmol/L
MgSO4 1.2 mmol/L; MgCl2 1.2 mmol/L; CaCl2 1.2 NAM; incubation with 2 mmol/L NAL; incubation with
mmol/L; glucose 5 mmol/L; alanine 1 mmol/L; Na lactate 25 mol/L FeHQ; incubation with 25 mol/L FeHQ 
4 mmol/L; Na butyrate 10 mmol/L; 36 kD dextran, 0.6%; 2 mmol/L NAM; and incubation with 25mol/L FeHQ
2 mmol/L NAL. A 15-minute pretreatment, followed bygassed with 95% O2/5% CO2; final pH 7.4) to a tubule
a 30-minute Fe challenge, was used, as above. At theprotein concentration of 2 to 4 mg/mL. Each PTS prepa-
end of the 45-minute incubations, % LDH release wasration was warmed to 37C, divided into 3 to 6 equal
determined.aliquots (1.25 or 1.5 mL, depending on the experiment),
RCM effects on isolated tubule viability and resistanceand placed into 10 mL Erlenmeyer flasks. They were
to superimposed injury. The following experiment wasthen used in individual experiments, as detailed below.
undertaken to ascertain whether RCM could exert directEffects of NAC on oxidative and hypoxic proximal
cytotoxicity on freshly isolated PTS, and whether suchtubular injury. NAC has been suggested to protect against
toxicity might sensitize tubular cells to either superim-human RCN [22], a process widely regarded as being
posed hypoxic or oxidative attack.mediated by oxidative stress and ischemic tubular injury.
Fe-mediated oxidative injury. Each of 4 sets of tu-Hence, the first set of experiments was undertaken to
bules were equally divided into 4 equal aliquots andexamine whether NAC can, indeed, block well-charac-
treated as follows: (1) control incubation for 45 minutes;terized forms of these types of tubular damage. Six sets
(2) incubation for 45 minutes with 200 L/mL of theof PTS were prepared and each was divided into 6 equal
nonionic contrast agent ioversol (Optiray 320, 68%; Mal-aliquots as follows: (1) control incubation (95% O2/5%
linckrodt, Inc., St. Louis, MO, USA; stock solution: 702CO2) for 45 minutes; (2) incubation for 45 minutes with
mmol/L; 320 mg/mL iodine); (3) 15-minute control incu-2 mmol/L NAC (Sigma Chemical Co., St. Louis, MO,
bation, followed by a 30- minute exposure to 25 mol/LUSA); (3) 15 minutes of control incubation followed
FeHQ; and (4) 15-minute pretreatment with RCM, fol-by a 30 minute oxidative challenge [25 mol/L ferrous
lowed by the 30-minute FeHQ challenge. The final RCMammonium sulfate, complexed with hydroxyquinoline
concentration raised buffer osmolality and iodide con-(HQ), a siderophore, allowing iron (Fe) to gain intracel-
centrations by 140 mosm/L and 64 mg/mL, respectivelylular access] [25, 26]; (4) 15 minutes of incubation with
(clinically achievable tubular intraluminal levels). After2 mmol/L NAC, followed by the 30 minute FeHQ chal-
45 minutes, injury was assessed by % LDH release. Oxi-lenge; (5) 15 minutes of control incubation followed by
15 minutes of hypoxia (95% N2/5% CO2)/15 minutes of dative damage (lipid peroxidation) was gauged by tubule
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oxygenated incubation followed by 20 minutes of RCMmalondialdehyde (MDA) content (nmol/mg tubule pro-
exposure. At the completion of the 30-minute incuba-tein) [28]. Ioversol was chosen for this study as it is
tions, samples were taken for assessment of ATP/ADPrepresentative of currently used nonionic contrast agents.
ratios and % LDH release. As a control for the osmoticA nonionic agent (rather than an ionic agent) was used
effect of contrast addition on posthypoxic cell injury, thebecause NAC was demonstrated to protect against non-
experiment above was repeated in two additional setsionic contrast agent in previous clinical trials [22, 23].
of tubules, substituting equiosmolar mannitol for RCM.Hypoxic cell injury. The above-mentioned experi-
Effect of NaI on proximal tubular cell integrity. RCMment was repeated, but hypoxia/reoxygenation (H/R)
can release inorganic iodide, resulting in its urinary ex-[26] was substituted for the Fe challenge. To this end,
cretion [32]. The following experiment was undertaken10 minutes of hypoxia (N2/CO2), followed by 20 minutes
to ascertain whether free iodide might contribute toof reoxygenation, were induced after the 15-minute RCM
RCM cytotoxicity. Three sets of tubules were each di-pretreatment period. Cell injury was again assessed by
MDA generation and % LDH release. vided into 4 aliquots as follows: 45-minute control incu-
Radiocontrast effects on proximal tubular segment ATP/ bations, and 45-minute incubations with 2.5, 5, or 10
ADP ratios. To ascertain potential RCM effects on mito- mmol/L NaI. LDH release and ATP/ADP ratios were
chondrial adenosine triphosphate (ATP) production, 6 then determined, as noted above.
sets of freshly isolated mouse proximal tubules were each Effects of RCM on plasma membrane stability and pro-
divided into 3 aliquots, and incubated for 45 minutes as tein shedding. The following experiments tested whether
follows: control incubation; incubation with 100 L/mL proximal tubular cell exposure to RCM de-stabilizes the
of RCM; or incubation with 200 L/mL of RCM. At the plasma/intracellular membranes, causing critical protein
completion of the incubations, a tubule aliquot was rapidly loss and enhanced membrane vulnerability to superim-
removed for subsequent determination of % LDH release, posed (e.g., PLA2) attack.
and then tubule adenine nucleotides were immediately Effect of RCM on tubule protein loss. Four sets of tu-
extracted in 6.67% trichloroacetic acid. After extraction, bules were divided into 4 aliquots with control incuba-
ATP and adenosine diphosphate (ADP) concentrations tion; incubation with 200 L/mL RCM; incubation with
were determined by high-pressure liquid chromatogra- 5 U/mL porcine pancreatic PLA2 (P6534; Sigma Chemical
phy (HPLC) [29, 30]. The state of cellular energetics was Co.), which is excluded from traversing the plasma mem-
gauged by determining ATP/ADP ratios [29, 30]. brane [33]; and RCM PLA2. After 45 minutes, % LDH
To determine whether increased plasma membrane release was determined, tubule aliquots were centrifuged
Na leak, with increased NaK-ATPase-driven ATP con- at 4C, and cell protein loss into the suspending medium
sumption, was responsible for RCM-induced reductions supernatant (protein concentrations; bichinchoninic acid
in ATP/ADP ratios, 3 sets of PTS were incubated as method) was assessed.
follows: control conditions; with 200 L/mL RCM; with Effect of RCM on NaK-ATPase and cytochrome c shed-
1 mmol/L ouabain (to block NaK-ATPase) [31]; or with ding. To ascertain specific sites of protein loss, superna-
RCM  ouabain. After 45 minutes, ATP/ADP ratios tants of tubule aliquots from the above experiment were
were assessed (see Results).
centrifuged, saved, and subjected to Western blot analy-To ascertain whether NAC could attenuate ATP/ADP
sis for NaK-ATPase as a marker of the plasma (basolat-reductions, 2 sets of tubules were incubated with 200
eral) membrane and cytochrome c, a mitochondrial inner
L/mL of RCM  2 mmol/L NAC. After 45 minutes,
membrane protein that can initiate apoptosis. WesternATP/ADP ratios were determined.
blots for NaK-ATPase (alpha 1 chain; Santa Cruz Bio-Effect of RCM on reoxygenation injury and post hypoxic
technology; Santa Cruz, CA, USA) and cytochrome cATP homeostasis. The experiments above indicate that
(BD PharMingen, #556433; San Diego, CA, USA) wereRCM can both increase hypoxia/reoxygenation-induced
conducted according to the manufacturer’s instructions,cell injury, as reflected by LDH release, and it can lower
and as previously described [34, 35]. Relevant proteinATP/ADP ratios in normal tubules. The following exper-
bands were visualized by enhanced chemiluminescenceiment was undertaken to ascertain whether RCM must
and quantified by densitometry [26].be present during hypoxia to exert this effect, or whether
Effect of RCM on caveolin shedding Caveolin is theits addition during reoxygenation can suppress recovery
dominant structural protein of plasma membrane rafts/of cellular energetics and increase reoxygenation-in-
caveolae (cholesterol/sphingomyelin enriched microdo-duced cell death. To this end, 4 sets of tubules were
mains associated with a myriad of signaling molecules)each divided into 4 equal aliquots as follows: control
[26]. The following experiment assessed whether RCMoxygenated incubation for 30 minutes; 10 minutes of
induces damage to these structures, as denoted by caveo-hypoxia followed by 20 minutes of reoxygenation; 10
lin loss [26]. Four sets of tubules were incubated usingminutes of hypoxia/20 minutes of reoxygenation, the lat-
control conditions; 200 L/mL RCM; RCM 2 mmol/Lter undertaken in the presence of 100 L/mL RCM
added at the start of reoxygenation; and 10 minutes of NAC; or equiosmolar mannitol as an osmotic control.
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After 45 minutes, % LDH release was determined, the 900 L of K-SFM (i.e., a 1:10 dilution), raising culture
medium osmolality by 70 mosm/L]; culture in the pres-samples were centrifuged, the supernatants concentrated
10 on a filter, and assayed for caveolin by Western ence of 1 mmol/L NAC; or culture with RCM  NAC.
After 3 days, cell injury was gauged by % LDH releaseblotting, as previously described [26].
RCM effects on plasma membrane susceptibility to and by MTT uptake assay (N  8 each).
RCM toxicity in HK-2 cells: influence of superoxideexogenous PLA2-induced deacylation. It is well rec-
ognized that during ischemic cell injury, PLA2 becomes dismutase and catalase. HK-2 cells were seeded into 24-
well cluster plates and the plates were divided into theactivated and induces plasma membrane phospholipid
deacylation, culminating in the accumulation of nones- following groups: control incubation; incubation with 250
U/mL of superoxide dismutase (SOD) (from bovineterified (free) fatty acids (NEFA) and lysophospholipids.
This experiment tested whether RCM directly causes erythrocytes, #S2515; Sigma Chemical Co.); incubation
with 5000 U/mL catalase (from bovine liver; C-40, Sigmadeacylation and/or sensitizes the plasma membrane to
PLA2 attack. Four sets of isolated tubules were each di- Chemical Co.); RCM of 100 L/mL; RCM  SOD; and
RCM catalase. After 3-day incubations, cell injury wasvided into 4 equal aliquots as follows: control incubation
for 30 minutes; incubation with 200 L/mL of RCM; incu- assessed by % LDH release and MTT uptake (N  8
determinations each).bation with 5 U/mL of porcine pancreatic PLA2; and
incubation with RCM PLA2. After the 30-minute incu- RCM toxicity in HK-2 cells: heme oxygenase and en-
dogenous GSH effects. To further gauge the role of oxi-bations, % LDH release was assessed, and the remaining
samples underwent lipid extraction in chloroform:meth- dant stress in RCM toxicity, two critical intracellular
antioxidant defense mechanisms, heme oxygenase andanol [33]. The lipid extracts were assayed for NEFA
with a commercially available kit (NEFA; Wako, Neuss, GSH, were inhibited/depleted, respectively, to ascertain
whether an exacerbation of RCM toxicity would result.Germany) [33]. Results were expressed as nmol/mg tu-
bule protein. To this end, 24-well plates of HK-2 cells were incubated
under one of the following conditions: control condi-Effect of RCM on hypoxia-induced deacylation. To fur-
ther test the hypothesis that RCM predisposes to PLA2- tions; incubation with 50 mol/L tin (Sn) protoporphy-
rin, a potent heme oxygenase inhibitor [37]; 1 mmol/Linduced membrane injury, intracellular PLA2-induced
deacylation was assessed, rather than porcine PLA2. L-buthionine sulfoximine dichloride (BSO) (Sigma Chemi-
cal Co.), an agent which induces80% glutathione deple-Four sets of tubules were each divided into 3 aliquots
containing control incubation 2 mmol/L glycine; 15 tion in HK-2 cells via GSH synthesis blockade [38]; RCM,
100 L/mL; RCM  50 mol/L Sn protoporphyrin; andminutes of hypoxia  2 mmol/L glycine; and 15 minutes
of hypoxia 200 L/mL RCM 2 mmol/L glycine. The RCM  BSO. Three days later, cell injury was assessed
by % LDH release and by MTT assay (N 8 determina-glycine was added to prevent, and hence, equalize, cell
death. At the end of the experiments, NEFA concentra- tions each).
RCM toxicity: effects of xanthine oxidase inhibition. Ittions and % LDH release were assessed.
has previously been hypothesized that adenosine accu-
Human proximal tubular (HK-2) cell experiments mulation, possibly the result of ischemia-induced ATP
degradation, can both induce renal vasoconstriction [7, 8]Cell culture methods. HK-2 cells, an immortalized
proximal tubular cell line derived from normal human and also fuel xanthine oxidase–mediated oxidase stress
[39]. The following experiments were undertaken to testkidney, were used for all of the following cell culture
experiments [36]. The cells were maintained at 37C with this view.
To determine whether RCM causes adenosine accu-20% O2/5% CO2 in T75 Costar flasks (Cambridge, MA,
USA) in keratinocyte serum–free medium (K-SFM) con- mulation, 18 T 75 flasks of HK-2 cells were divided into
3 groups: control incubation for 3 hours; incubation withtaining 1 mmol/L glutamine, 5 ng/mL epidermal growth
factor, 40 g/mL bovine pituitary extract, 25 U/mL peni- RCM (100 L/mL of culture medium); or incubation
with equiosmolar mannitol. After 3 hours, the cells werecillin, and 25 g/mL streptomycin [36]. At near conflu-
ence, the cells were trypsinized and transferred to either extracted and assayed for ATP, ADP, adenosine mono-
phosphate (AMP), and adenosine levels [30]. The experi-additional T75 flasks (for passage) or to 24-well Costar
plates (for specific experiments). Cell injury in these mental values were expressed as nmol recovered per
flask.experiments was assessed either by determining % LDH
release, or by tetrazolium dye (MTT) uptake assay [36]. To determine whether xanthine oxidase inhibition mit-
igates RCM toxicity, 2 24-well cluster plates were eachRCM toxicity in the presence and absence NAC. HK-2
cells were trypsinized and seeded into 24-well cluster seeded with HK-2 cells and 8 hours later were subdivided
as follows: control incubation; incubation with RCM,plates. Approximately 8 hours later, the cells were main-
tained under one of the following conditions for 3 days: as noted above; incubation with 50 mol/L oxypurinol
(Sigma Chemical Co.); incubation with 100 mol/L oxy-normal culture conditions; with RCM [100 L added to
Zager, Johnson, and Hanson: Radiographic contrast media–induced tubular injury132
purinol; RCM  50 mol/L oxypurinol; and RCM 
100 mol/L oxypurinol. Three days later, cell injury was
assessed by % LDH release.
Hyperosmolality as a mediator of RCM toxicity. It has
previously been suggested that RCM toxicity is mediated
via inducing osmotic shock, possibly triggering apoptosis
[17, 18]. The following experiment addressed whether
this is the sole mechanism for RCM-induced cytotoxicity.
HK-2 cells, grown in 24-well cluster plates, were divided
into 3 groups: control incubation; incubation with 100L
RCM/mL culture medium (final increase in osmolality of
70 mosm/L); or an equal osmotic dose (70 mosm/L) of
mannitol. After 3 days, cell injury was assessed by % LDH
release and MTT uptake, as above. Fig. 1. Relative effects of N acetyl cysteine (NAC) and glutathione
Iodide as a potential mediator of RCM toxicity. As- (GSH) on iron (Fe) and hypoxia/reoxygenation (H/R)-induced injury
to isolated proximal tubular segments (PTS). As shown in the lefthandsessment of iodide toxicity. Two 24-well plates of HK-
panel, 2 mmol/L NAC almost completely blocked Fe-hydroxyquinoline2 cells were divided into 3 treatment groups: control (FeHQ)-mediated injury. However, it exerted only a slight, albeit statis-
incubation; incubation with 1.25 mmol/L NaI; and incu- tically significant, protective effect against H/R injury (15 minutes’
hypoxia/15 minutes’ reoxygenation). As shown in the righthand panel,bation with 2.5 mmol/L NaI. After 3 days, toxicity was
2 mmol/L GSH induced comparable protection against Fe-mediatedsought by % LDH release. injury, compared to NAC. However, GSH was far more protective
Does propylthiouracil (PTU) inhibit RCM cytotox- against H/R injury than was NAC (undoubtedly due to GSH’s glycine
content; see text).icity? Propylthiouracil (PTU) can block iodide-mediated
apoptosis [40] purportedly by inhibiting iodide incorpora-
tion into cellular proteins. Hence, potential PTU-induced
protection against RCM toxicity was sought. Two plates
NAC, which minimally impacted H/R injury, GSH com-of HK-2 cells were incubated under control conditions 
pletely blocked H/R induced cell death.250 or 500 mol/L PTU; and with RCM  250 or 500
N acetyl lysine (NAL)/N acetyl methionine (NAM) ef-
mol/L PTU. Three days later, % LDH release was
fects on FeHQ-induced injury. Unlike NAC and GSH,assessed.
neither NAL nor NAM protected against Fe-mediatedCalculations and statistics. All values are presented as
cell death (% LDH release: control, 12  2%; Fe, 50 mean  SEM. Statistical comparisons were performed
2%; Fe  NAM, 53  2%; Fe  NAL, 50  2%; allby either paired or unpaired Student t test. If multiple
NS). NAL or NAM did not independently affect LDHcomparisons were made, the Bonferroni correction was
release (10 to 12% LDH release for all control, NAL,applied. Of note, the two major end points of toxicity
and NAM exposed tubules).used in this study, MTT uptake and LDH release, were
RCM effects on isolated tubule viability and cell injuryfirst demonstrated not to be artifactually altered by RCM
responses. The addition of 200 L/mL of RCM to PTSaddition (assessment of these end points when the RCM
had no significant effect on tubule viability in the absencewas added, followed immediately by LDH and MTT
of another challenge (Fig. 2). RCM caused a modest, butassay).
significant, worsening of hypoxic/reoxygenation injury.
However, RCM addition failed to potentiate Fe-mediated
RESULTS injury; rather, a paradoxical trend toward decreased, rather
Isolated proximal tubule experiments than increased, LDH release resulted (Fig. 2, right).
RCM addition did not increase PTS MDA concentra-NAC and GSH effects on oxidant and hypoxic injury
tions, either on its own or when present during superim-to isolated tubular segments. As shown in Figure 1, left
posed H/R or Fe-mediated injury (Fig. 3); rather, a slight,panel, both FeHQ and hypoxic/reoxygenation (H/R) in-
but nonsignificant, trend toward RCM-associated MDAjury induced50% LDH release. NAC treatment exerted
reductions was observed.significant protective effects. This was most dramatic in
RCM effects on proximal tubular segment ATP/ADPthe case of Fe-induced oxidant injury, with % LDH re-
ratios. Incubating tubules for 45 minutes with either 100 orlease barely rising around baseline values. NAC caused
200 L/mL of RCM caused a dose- dependent decreaseonly a minor suppression of H/R injury. NAC by itself
in ATP/ADP ratios (Fig. 4, left). This corresponded withdid not alter % LDH release.
only slight, and nonsignificant, changes in % LDH re-As shown in Figure 1, right panel, GSH caused an
lease (Fig. 4, right).approximate 50% decrease in Fe-mediated LDH release
(largely recapitulating NAC’s effect). In contrast to To differentiate between increased ATP consumption
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Fig. 4. Radiocontrast medium (RCM) effects on proximal tubule aden-
osine triphosphate (ATP)/adenosine diphosphate (ADP) ratios and cell
injury, as assessed by % lactate dehydrogenase (LDH) release. RCM,
either 100 or 200 L/mL, induced a modest, dose-dependent decrease
Fig. 2. Radiocontrast medium (RCM) effects on proximal tubule via- in ATP/ADP ratios (left panel). This was associated with a concomitant
bility in the presence or absence of superimposed hypoxia/reoxygenation slight upward trend in % LDH release, a change that did not achieve
(H/R) or iron (Fe)-mediated injury. RCM addition (200 L/mL) did not, statistical significance (right panel).
by itself, increase % lactate dehydrogenase (LDH) release (left and right
panels). RCM did significantly exacerbate 10 minutes’ hypoxic/20 min-
utes’ reoxygenation injury. Conversely, RCM did not worsen Fe-medi-
ated cell death.
Fig. 5. Effect of radiocontrast medium (RCM) addition on posthypoxic
(reoxygenation) adenosine triphosphate (ATP)/adenosine diphosphate
(ADP) ratios and posthypoxic lactate dehydrogenase (LDH) release.
RCM (100 L/mL) and hypoxia/reoxygenation (H/R) injury each
caused significant declines in tubule ATP/ADP ratios (left panel). How-
ever, when RCM and H/R were present together, no synergistic decrease
in ATP/ADP ratios resulted. Addition of RCM upon reoxygenationFig. 3. Radiocontrast medium (RCM) effects on proximal tubular lipid
caused a modest, but significant, worsening of cell injury, as assessedperoxidation, as assessed by malondialdehyde (MDA) concentrations.
by % LDH release.RCM addition did not cause a spontaneous increase in tubule MDA
levels. Whereas iron (Fe) induced a dramatic increase in MDA (as
would be expected from an oxidant form of injury), RCM did not
augment the Fe-driven MDA increments. Hypoxia/reoxygenation (H/R)
injury was not associated with MDA generation, either in the presence
or absence of RCM. above, were not attenuated by NAC administration (data
not shown).
RCM effects on reoxygenation ATP/ADP ratios and re-
oxygenation injury. ATP/ADP. As shown in Figure 5,(due to NaK-ATPase activity) and decreased ATP produc-
left, addition of 100 L/mL of RCM caused a modesttion, the impact of 1 mmol/L ouabain on RCM-induced
reduction in ATP/ADP ratios in normal tubules (P 	ATP/ADP ratio suppression was assessed. Ouabain failed
0.035). Following hypoxic/reoxygenation (H/R) injury,to improve the RCM-induced ATP/ADP ratio reduc-
an approximate 35% reduction in ATP/ADP ratios wastions; rather, a slight additional worsening of the ratios
apparent, compared to normal tubules (P 	 0.05). Thewas observed (control, 8.2 0.4; RCM, 7.1 0.3; RCM
combination of RCM  H/R injury caused additive, notouabain, 5.7  0.3). Thus, RCM likely suppressed mito-
synergistic, ATP/ADP reductions in posthypoxic tu-chondrial ATP generation, rather than increased ATP
bules.consumption (i.e., via a NaK-ATPase-dependent mecha-
nism). RCM-induced ATP/ADP ratio reductions, as noted % LDH release. Addition of RCM solely during re-
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Fig. 6. Effect of radiocontrast medium (RCM) with and without phos-
pholipase A2 (PLA2) on % lactate dehydrogenase (LDH) release and
free (nonesterified) fatty acid (FFA) levels in isolated tubules. RCM
and PLA2, or the two together, had minimal effects on % LDH release.
In contrast, PLA2 induced an increase of 7 times in free fatty acid (FFA)
levels. RCM doubled the amount of PLA2-induced FFA increases,
despite the fact that RCM treatment by itself did not increase FFA
content.
Fig. 7. Western blot analysis of NaK-ATPase released into tubule me-
dia. The protein band appears at 112 kD. As can be seen, the control
sample demonstrated virtually no NaK-ATPase (alpha 1 chain). Both
oxygenation caused a slight worsening of H/R injury. radiocontrast medium (RCM) and phospholipase A2 (PLA2) exposure
induced NaK-ATPase release (P	 0.01 vs. controls). Combined PLA2Thus, when viewed in the context of the Figure 2 data,
RCM treatment yielded significantly more NaK-ATPase than eitherit appears that RCM can exacerbate H/R injury whether treatment alone (P 	 0.01). Statistics were conducted by converting
the RCM is present during hypoxia or in the reoxygena- density units into log base 10, followed by unpaired Student t test with
Bonferroni correction.tion period. Not depicted, equiosmolar mannitol slightly
lessened, not worsened, reoxygenation LDH release (43
0.3% vs. 40  0.3%, P  0.05). Thus, RCM’s adverse
effect on H/R injury was not mediated by an increase mediated NEFA accumulation under conditions where
lethal cell injury was prevented by glycine treatment.in osmolality.
RCM effects on membrane protein loss. Total pro-NaI incubation with proximal tubule segments. Incu-
tein. RCM caused significant tubule protein loss into thebating tubules for 45 minutes with 2.5, 5, or 10 mmol/L
suspending media (protein concentration: RCM, 0.2 NaI had no demonstrable adverse effect on cell viabil-
0.02 vs. control, 0.12  0.02; P 	 0.0001). PLA2 alsoity, as reflected by completely normal % LDH release
increased protein loss, but the combination of RCM (
11% for all aliquots; control, 11%). ATP/ADP ratios
PLA2 caused only a small additional increment (PLA2were also unaffected by NaI incubations (8.0  0.1 for
alone, 0.38 0.02 mg/mL vs. PLA2  RCM, 0.44 0.02;all doses of NaI vs. 7.8  0.2 for control tubules, not
P 	 0.05). It had previously been determined that thedepicted).
employed RCM dosage did not affect the employed pro-RCM effects on plasma membrane deacylation: suscep-
tein assay method.tibility to exogenous PLA2. As shown in Figure 6 (right
NaK-ATPase. Western blotting demonstrated thatpanel), PLA2 induced a 6- to 7-fold increase in NEFA
RCM caused significant shedding of NaK-ATPase (alphalevels in the absence of a significant increase in cell death
chain; 112 kD) into the tubule medium (control, nonde-(LDH release). The extent of PLA2-induced deacylation tected; RCM, 85  40 density units) (Fig. 7). PLA2 alsowas doubled by the presence of RCM. Again, no signifi-
caused NaK-ATPase shedding, a result which was dra-
cant worsening of cell death resulted (Fig. 6, left panel). matically and synergistically increased by the presence
The RCM effect on PLA2-mediated deacylation oc- of RCM. As noted above (Fig. 6, left), there was a lack
curred without RCM exerting an independent effect on of a significiant increase in % LDH release, indicating
NEFA concentrations. that this NaK-ATPase loss was not simply a nonspecific
RCM effect on hypoxia (endogenous PLA2)-induced result of RCM- or PLA2-induced cell death.
deacylation. The presence of glycine prevented any hyp- Cytochrome c. As shown in Figure 8, RCM caused
oxia-induced increase in % LDH release (10 to 14% dramatic cytochrome c loss into tubule buffer (seen at
for all aliquots, not shown). NEFA concentrations at the 15 kD). This was also found with PLA2. However, RCM
end of experiments were as follows: control incubation, PLA2 did not exert a synergistic effect on cytochrome c
10  1; hypoxia, 31  3; and hypoxia  RCM, 40  3 shedding. Again, there was a lack of increase in % LDH
(nmol/mg protein; P 	 0.05 vs. hypoxia alone). Hence, release, indicating that the cytochrome c loss was not
simply a nonspecific response to cell death.the presence of RCM increased the extent of hypoxia-
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Fig. 10. Effect of radiocontrast medium (RCM)  N acetyl cysteine
(NAC) on HK-2 cell viability, as assessed by tetrazolium dye (MTT)
uptake or lactate dehydrogenase (LDH) release assay. Incubating HK-2
cells with RCM for 3 days caused significant toxicity, as reflected by
reduced MTT uptake and increased LDH release. NAC did not attenu-
ate this toxicity, as assessed by either assay. NAC, by itself, slightlyFig. 8. Western blot analysis of cytochrome c release into tubule media.
increased MTT uptake.The protein band appears at 15 kD. Both radiocontrast medium (RCM)
and phospholipase A2 (PLA2) induced extremely large increases in
cytochrome c release, compared to control tubules (P	 0.01 and	0.001,
respectively). Combined RCM  PLA2 caused more cytochrome c loss
than did RCM alone (P 	 0.035). lality. NAC treatment did not diminish the RCM-induced
caveolin increases, consistent with a lack of a protective
effect (as described below). In none of the incubations
did a significant increase in % LDH release result (
14%,
all samples), indicating that the caveolin loss was not
simply due to cell death.
HK-2 cell experiments
RCM toxicity in the presence or absence of NAC, cata-
lase, and SOD. RCM induced significant HK-2 cell in-
jury, as indicated by both a 50% reduction in MTT dye
uptake (which directly correlates with viable cell num-
bers) [34], and by a significant increase in LDH release
(Fig. 10; black bars, white bars: RCM, no RCM, respec-
tively). NAC, by itself, slightly increased MTT uptake in
the absence of RCM. However, NAC completely failed
to protect against RCM toxicity, as assessed by either
MTT assay or LDH release. Furthermore (not depicted),
neither catalase (Cat) nor SOD exerted any protective
effect against RCM, as assessed by either MTT uptake
Fig. 9. Western blot analysis of caveolin release into tubule media. (50% reductions with RCM  Cat or  SOD) or by
The protein band was observed at 22 kD. Only trivial amounts of % LDH release (control, 8 to 10%; RCM, 30  1%,caveolin were observed in samples obtained from tubules maintained
RCM Cat, 32 21%; RCM SOD, 30 1%; all NS).under control conditions or treated with mannitol. However, radiocon-
trast medium (RCM) treatment caused marked caveolin release (P 	 HK-2 cell RCM toxicity: effects of Sn protoporphyrin
0.01 vs. controls), a result which was not diminished by N acetyl cysteine and BSO. Heme oxygenase inhibition with Sn protopor-(NAC) treatment.
phyrin had no discernible independent effect on HK-2
viability, as assessed by MTT uptake or % LDH release
(Fig. 11). It also failed to increase RCM toxicity, as
assessed by either assay method. Rather, Sn protopor-Caveolin. Media obtained from tubules incubated un-
phyrin seemed to reduce RCM toxicity, as assessed byder control conditions showed a barely discernible caveo-
% LDH release.lin band at 22 kD (Fig. 9). Conversely, RCM treatment
BSO caused significant toxicity in HK-2 cells, as indi-caused a marked increase in caveolin expression (P 	
cated by a 50% reduction in MTT uptake (Fig. 11).0.01 vs. control). Noteworthy was that mannitol did not
Despite this toxicity, it did not predispose to RCM toxic-cause increased caveolin release, indicating that RCM’s
effect was not simply due to an increase in media osmo- ity, since comparable reductions in MTT uptake oc-
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Fig. 11. Tin protoporphyrin (SnP) and L-buthionine sulfoximine di-
chloride (BSO) effects on radiocontrast medium (RCM) HK-2 cell Fig. 12. Equiosmolar radiocontrast medium (RCM) versus mannitoltoxicity. SnP had no significant effect on HK-2 cell viability in the on HK-2 cell viability. Mannitol caused a modest decrease in tetrazoliumabsence of RCM. It also failed to worsen RCM toxicity. Rather, a dye (MTT) uptake (consistent with either an antiproliferative effectparadoxical decrease in RCM-induced lactate dehydrogenase (LDH) or sublethal toxicity). However, it did not cause an increase in lactaterelease was observed. BSO caused significant cytotoxicity in the absence dehydrogenase (LDH) release. Conversely, RCM caused a marked sup-of RCM. However, in the presence of RCM, it failed to exacerbate cell pression of MTT uptake, as well as a significant increase in % LDHdeath. Thus, these experiments indicated that depleting/inhibiting two release. Thus, RCM cytotoxicity cannot be fully attributed to a hyperos-important antioxidants [heme oxygenase and glutathione (GSH), re- molar state. Assessments were made after 3 days’ RCM exposure.spectively] had no effect on the severity of RCM toxicity. Symbols are:
() without RCM; () with RCM. Assessments were made after 3
days’ RCM exposure.
Table 1. HK-2 cell adenine nucleotide profiles under control
conditions and following 3-hour exposures to either equiosmolar
mannitol or radiographic contrast medium (RCM)curred whether or not RCM was present. BSO also failed
Group ATP ADP AMP TAN Adenosineto increase RCM-mediated LDH release. Thus, in sum,
the above experiments indicated that neither heme oxy- Control 723 5.61 1.50.2 803 3.20.6
Mannitol 661d 4.50.5d 1.20.1d 711d 4.20.05dgenase inhibition nor GSH depletion predisposed HK-
RCM 592a 4.10.2 0.60.1a 642b 9.60.04c2 cells to RCM-mediated cell death.
Abbreviations are: ATP, adenosine triphosphate; ADP, adenosine diphos-RCM toxicity: effects of xanthine oxidase inhibition.
phate; AMP, adenosine monophosphate; TAN, total adenine nucleotide. ATP,
Oxypurinol, the xanthine oxidase inhibitor, did not con- ADP, AMP, and TAN profiles are shown compared to the control. Radiographic
contrast medium (RCM) treatment for 3 hours caused significant reductions infer protection against RCM toxicity, as assessed by %
ATP and ADP, resulting in a decrease in TAN, and an increase in adenosine
LDH release. After 3-day RCM exposures, % LDH re- content. Equiosmolar mannitol showed a slight, nonsignificant effect on adenine
nucleotides compared to the control. Values are given as nmol/flask.lease for control, RCM, RCM  50 mol/L oxypurinol,
aP 	 0.01 vs. control
and RCM  100 mol/L oxypurinol were 6  0.5%, bP 	 0.01 and 	0.05 vs. control and mannitol, respectively
cP 	 0.001 vs. control and mannitol26  0.4%, 27  0.4%, and 25  0.5%, respectively.
dNS vs. control
Oxypurinol did not exert independent toxicity, as assessed
by LDH release (5 to 7% for all control and oxypurinol
samples). The failure of oxypurinol to confer protection
against RCM toxicity was observed, despite the fact that Iodide as a potential cytotoxic agent. Inorganic iodide
RCM addition to HK-2 cells caused an increase of three (1.25 or 2.5 mmol/L) caused no cytotoxicity, as assessed
times in adenosine concentrations (Table 1). The in- by LDH release (all control and NaI values 
5%). Fur-
crease in adenosine was associated with a decrement in thermore, PTU did not block RCM’s cytotoxic effect:
total adenine nucleotide (TAN) (ATP ADP  AMP) [control, 5  1%; PTU, 5  1%; RCM, 17  1% (P 	
content. 0.001 vs. control); RCM  PTU, 17  1%].
Mannitol vs. RCM effects on HK-2 viability. As shown
in the lefthand panel of Figure 12, both mannitol and
DISCUSSIONRCM caused significant decreases in MTT uptake. How-
In 2000, Tepel et al [22] reported that NAC givenever, the degree of suppression was approximately twice
prior to and the day of RCM administration significantlyas great with RCM, indicating that its cytotoxicity was
reduced the risk of ARF. Given the lack of other specificnot simply the result of hyperosmolality. This point was
agents for preventing RCN (excepting NaCl loading),underscored by the fact that RCM, but not mannitol,
this positive finding has led to NAC’s frequent use incaused a significant increase in LDH release (Fig. 12,
the clinical setting. Because NAC can function as anright). Lastly, as shown in Table 1, while mannitol caused
antioxidant, it has been assumed that this action is re-a trend toward decrements in adenine nucleotides, sig-
sponsible for its protective influence. However, NACnificant reductions were only observed with RCM treat-
ment. may also attenuate RCM-induced renal vasoconstriction
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[41]. Furthermore, it remains to be proven that NAC’s observed. The negative result with oxypurinol was partic-
ularly noteworthy, given that RCM addition to HK-2protective action stems solely from its free sulfhydryl,
versus its acetyl, content [41]. Given these considera- cells induced an increase of three times in adenosine, an
‘upstream’ substrate for xanthine oxidase. Pursuing thetions, NAC-mediated protection cannot necessarily be
equated with an antioxidant effect expressed at the tubu- reverse strategy, we attempted to sensitize HK-2 cells
to potential RCM-induced oxidant stress by blockinglar cell level.
To gain further insight into this issue, we sought to endogenous antioxidant pathways (inhibition of heme
oxygenase with Sn protoporphryin, glutathione deple-demonstrate that NAC can mitigate proximal tubular
oxidant injury, and that this effect is, indeed, dependent tion with BSO). However, neither of these approaches
exacerbated RCM-induced damage. The latter resultson the compound’s sulfhydryl content. NAC almost com-
pletely blocked Fe-mediated cell death in isolated tu- were particularly noteworthy, given that BSO on its own
was cytotoxic (indicating the susceptibility of HK-2 cellsbules; conversely, neither NAL nor NAM exerted any
protective effect. This supports the notion that NAC’s to oxidant stress), and Sn protoporphyrin paradoxically
mitigated RCM cytotoxicity. Hence, these HK-2 resultsprotective action is, indeed, a function of itsSH, rather
than its acetyl (or sulfur), content. It is notable that both are compatible with the isolated tubule data, indicating
a lack of RCM- induced oxidant stress. It should be notedrenal ischemia and oxidative stress are thought to be
critical pathogenic factors in RCM nephropathy. Be- that these in vitro results are not necessarily in conflict
with in vivo clinical data. For example, while Tepel etcause GSH can potentially block both injury pathways
by providing cytoprotective glycine [27] plus functioning al [22] found positive results with NAC against RCN,
Briguori et al [23] failed to show protection, except in aas an antioxidant, relative NAC versus GSH-mediated
protection was assessed. Whereas each induced compa- small subset of retrospectively analyzed patients. Fur-
thermore, two additional recent studies each reportedrable protection against oxidant tubular stress, only GSH
completely blocked hypoxic cell death. This raises the that NAC exerted no protective effect [42, 43]. Thus, our
findings that NAC did not blunt in vitro RCM toxicity arepossibility that GSH (or the combination of NAC 
glycine) might be a more potent cytoprotective strategy consistent with these latter two reports.
A hypertonic milieu (e.g., resulting from high dosethan NAC monotherapy.
NAC’s ability to protect tubular cells against RCM mannitol or sucrose injection) has frequently been linked
to the induction of tubular injury and clinical ARF. Thistoxicity is predicated on the assumption that RCM, in
fact, mediates oxidative stress. To evaluate this issue, raises the issue of the relative importance of hyperosmo-
lality versus compound-specific toxicity in RCN-inducedisolated tubules were incubated with RCM, followed by
assessments of lethal cell injury (LDH release), and tubular damage. This issue has previously been debated.
For example, Humes et al [19] suggested that hyperos-MDA generation. Furthermore, the ability of RCM to
exacerbate superimposed oxidative and hypoxic/reoxy- molality was not a major factor, based on his studies in
isolated tubule segments. However, studies by Hizohgenation injury was assessed. Surprisingly, no evidence
in support of RCM-induced oxidative stress could be and Haller [17] suggested that osmolar changes may be
primary, given that both hypertonic NaCl and RCMgleaned from these experiments: RCM did not increase
tubular MDA content; RCM did not predispose cells to caused DNA fragmentation in cultured MDCK tubular
cells. Because NaCl, unlike contrast agents, undergoessuperimposed Fe-mediated oxidative stress; and while
RCM potentiated hypoxic cell injury [19], this change active transport, conclusions based on it are not necessar-
ily germane. Therefore, in the present study, HK-2 cellswas dissociated from any increase in MDA content.
Thus, in sum, no evidence for RCM-induced oxidative were incubated with RCM or with equiosmolar mannitol
(as a nontransported solute matched control) and resul-stress could be gleaned from any of these isolated tubule
experiments. tant toxicities were compared. While each factor may
play a role, compound specific toxicity appears to beA major limitation underlying these isolated tubule
studies is that this model permits only limited incubation dominant, as indicated by the following: although both
mannitol and RCM suppressed MTT uptake, the reduc-periods (generally 
1 hour), potentially too short for
lethal RCM cytotoxicity to develop. To circumvent this tions were approximately twice as great with RCM treat-
ment; only RCM induced membrane disruption, as as-problem, additional studies were conducted using a more
prolonged model of RCM toxicity: incubation of HK-2 sessed by LDH release; RCM, but not mannitol, caused
significant declines in tubule cell ATP; and RCM, butcells with RCM for 3 days, followed by assessments of
toxicity by MTT dye uptake and/or by % LDH release. not mannitol, caused plasma membrane caveolin release
(see below).In an effort to prove a mechanistic role for oxidative
stress in RCM toxicity, protection against it was sought While the molecular determinant of RCM cytotoxicity
remains unknown, it is intriguing to speculate upon theusing a wide variety of antioxidants, including NAC,
SOD, catalase, or oxypurinol. In no case was protection possibility that it stems from its iodine content. Following
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RCM administration, small amounts of iodide (ranging integrity, and ultimately, membrane susceptibility to at-
tack. Several pieces of experimental evidence have beenfrom 0.5 to 5% of the total administered dose) are re-
leased and excreted in urine [32]. Iodide is a preferential gathered to support this “membrane injury” hypothesis.
First, RCM addition to proximal tubules caused a rapidsubstrate for peroxidase-mediated free radical (hypoio-
dous acid) generation, and protein iodination/denatur- loss of cell protein into the suspending media. That this
was paralleled by the loss of two critically importantation can result [40]. Hence, we considered the possibility
that iodide might mediate some of RCM’s cytotoxic ef- plasma membrane proteins (NaK-ATPase and caveolin)
supports the concept of RCM-induced “membrane de-fects. However, NaI addition did not adversely impact
isolated tubule or HK-2 cell viability, as assessed by stabilization,” and indicates potential mechanisms by
which RCM might disrupt cell integrity. Second, RCMATP/ADP ratios and/or LDH release. Furthermore,
PTU, which blocks protein iodination, exerted no protec- dramatically sensitized the plasma membrane to exoge-
nous PLA2 attack. This was evidenced by synergistictive effect. Thus, the concept that free iodide is linked
to RCM toxicity appears unlikely. NaK-ATPase loss with RCM  PLA2; an RCM-induced
doubling of exogenous PLA2-induced deacylation; andAs previously noted by Humes et al [19], RCM can
impair mitochondrial energetics, resulting in reductions increased hypoxia-induced deacylation in the presence
of RCM, despite “clamping” lethal cell injury with gly-in tubular ATP. Our results are consistent with this con-
clusion, given that RCM addition caused ouabain-resis- cine. It is notable that PLA2-induced deacylation is a
critical determinant of ischemic and hypoxic cell damage.tant tubular ATP declines, as well as a depression in
HK-2 cell ATP content. However, only 15 to 20% ATP That this process was greatly enhanced in the presence
of RCM provides an important new insight into mecha-reductions were observed. Given that 50% and 90%
ATP depletion are thought to be required to induce nisms by which RCM predisposes to ischemic and hyp-
oxic cell death (e.g., Figs. 3 and 6).tubular cell apoptosis and necrosis, respectively [44], it is
highly unlikely that the presently observed ATP declines
were sufficient, by themselves, to induce lethal cell dam-
CONCLUSION
age. Hence, we sought a second potential mechanism
The present study provides the following new insights:by which mitochondrial injury might give rise to RCM
RCM-induced cytotoxicity can be dissociated from tubu-toxicity.
lar cell oxidant stress (at least in vitro). This is consistentUnder normal circumstances, cytochrome c is associ-
with recent findings [23, 42, 43] that NAC may not pre-ated with the inner mitochondrial membrane. However,
vent clinical RCM-induced ARF; RCM toxicity cannotwith mitochondrial injury, it reaches the cytosol, where
solely be explained by the induction of a hypertonicit can initiate caspase activation and ultimately cell death.
milieu, as previously suggested; rather, direct compound-Given its low molecular weight (15 kD), we hypothesized
related toxicity appears to play the dominant pathogenicthat released cytochrome c should readily traverse the
role; the molecular basis for RCM-mediated cytotoxicityplasma membrane, thereby being detectable in isolated
remains elusive at this time. However, release of inor-tubule buffer if prior mitochondrial release occurs. In-
ganic iodide, with subsequent iodide toxicity, appearsdeed, this appeared to be the case. With RCM addition,
not to be involved; and RCM can de-stabilize the plasma,dramatic cytochrome c loss into the cell supernatant solu-
and potentially, the mitochondrial membranes. This cantion was observed in the absence of increased LDH re-
result in the loss of critical plasma membrane (e.g., NaK-lease. It is notable that sublethal doses of pancreatic
ATPase, caveolin), and mitochondrial (cytochrome c)PLA2, which primarily attacks the plasma membrane and
proteins, and an increase in plasma membrane suscepti-secondarily depresses mitochondrial function [31], also
bility to PLA2 attack. Given the importance of each of thecaused cytochrome c release. This suggests that RCM-
above processes to cellular integrity, the current findingsinduced mitochondrial damage, as reflected by cyto-
provide new potential insights into mechanisms of RCMchrome c leak, is a downstream result of plasma mem-
tubular toxicity and its associated ARF. Whether thebrane damage. That neither PLA2 nor RCM caused lethal
above observations, gathered using tubular cells, alsocell injury (increased LDH release) in these experiments
have relevance to endothelial cells remains unknownindicates that the cytochrome c loss into the tubule media
at this time. However, given that vasoconstriction is areflected a prelethal tubular cell event. The link between
consequence of RCM adminstration, this represents anplasma membrane injury and secondary mitochondrial
interesting question that potentially deserves future in-damage, and the ultimate role of cytochrome c release
vestigation.in the expression of RCM toxicity (e.g., potential induc-
tion of apoptosis), will each require substantial addi-
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